Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs
Description
Oral antivirals have the potential to reduce the public health burden of COVID-19. However, now that we have exited the emergency-phase of the COVID-19 pandemic, declining SARS-CoV-2 clinical testing rates (average testing rates = [Formula: see text
